What is asthma?
Asthma is a long-term disease that affects your airways. It occurs when your airways become swollen and inflamed. Swelling is a reaction to things that you are allergic to or find irritating. When the airways react, they get narrower and less air flows through to your lungs. Cells in the lungs produce extra mucus, further narrowing your airways. This makes breathing hard and causes wheezing. This is called an asthma attack. Attacks are also called flare-ups, exacerbations or episodes. Asthma can be controlled so that you have fewer symptoms. Controlling it means taking medicines as directed by your caregiver and staying away from things that bother your airways, such as cigarette smoke. With treatment, asthma can be managed so you are able to live a normal life.
Asthma Clinical Research Trials
AZ2210C00007: A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Asthma Inadequately Controlled on Inhaled Corticosteroid Plus Long-Acting ?2-Agonist
Purpose: A 52-Week, Multicentre, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab, a drug which is a looking to reduce lung inflammation in Adults and Adolescents with Asthma Inadequately Controlled on Inhaled Corticosteroid Plus Long-Acting ?2-Agonist. Long-acting beta2-agonists (bronchodilators) relax the smooth muscles lining the airways that carry air to the lungs. This allows the tubes to stay open longer and makes breathing easier.
For All Studies:
Qualified participants will receive study-related care, study-related exams and study-related medication at no cost. Participants may be compensated for their time and travel.
If you are interested in participating in a study or would like more information, register now or contact The Lung Research Center at 314-439-LUNG (5864) or email: email@example.com.